SUIC SUIC Worldwide Holdings Ltd.
Industrial Organic Chemicals · OTC · SEC CIK 1394108 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY164.1%
TTM net income YoY78.0%
TTM EPS YoY-102.6%
Revenue 3-yr CAGR-40.2%
Net income 3-yr CAGR—
Margins
Gross margin55.6%
Operating margin-45.2%
Net margin-234.4%
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-403.3%
ROIC (approx.)—
Asset turnover1.72x
Leverage & solvency
Liabilities / assets20,510.1%
Debt / equity—
Current ratio0.00x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.63x
Accruals ratio-148.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $20,000 | $0 | $18,482 | $0 | $0 | -$90,000 | $30,000 |
| Cost of revenue | $0 | $10,000 | $0 | $7,100 | $0 | $0 | -$13,278 | $400 |
| Gross profit | $0 | $10,000 | $0 | $11,382 | $0 | $0 | -$76,723 | $29,600 |
| SG&A expense | $8,730 | $18,658 | $12,259 | $16,113 | $23,607 | $12,038 | $148,497 | $83,622 |
| Operating income | -$8,730 | -$8,658 | $0 | $0 | -$23,607 | -$12,038 | $3,168 | $378 |
| Interest expense | $4,056 | — | — | — | $4,376 | — | — | — |
| Pretax income | -$15,201 | -$15,035 | -$48,746 | -$11,221 | -$29,695 | -$29,981 | -$260,608 | -$89,218 |
| Income tax | $0 | $0 | — | — | $0 | $0 | — | — |
| Net income | -$15,201 | -$15,035 | -$48,746 | -$11,221 | -$29,695 | -$29,981 | -$260,608 | -$89,218 |
| EBITDA | — | — | — | — | — | — | $3,180 | $391 |
| EPS (basic) | 0.00 | — | — | — | 0.00 | — | — | — |
| EPS (diluted) | 0.00 | — | — | — | 0.00 | — | — | — |
| Weighted avg. shares (diluted) | 31.57M | — | — | 290.40M | 290.40M | 290.40M | — | 290.40M |
| Banking | ||||||||
| Net interest income | — | — | — | — | — | $3,008 | — | $1,134 |
| Balance sheet | ||||||||
| Cash & equivalents | $2,987 | $12,195 | $8,560 | $7,512 | $9,279 | $14,466 | $38,495 | $13,079 |
| Short-term investments | — | — | — | — | $30,000 | $31,231 | — | $30,000 |
| Receivables | — | — | — | $1,231 | — | — | — | $220,824 |
| Current assets | $2,987 | $12,195 | $8,560 | $7,512 | $39,279 | $14,466 | $38,495 | $353,902 |
| Total assets | $4,218 | $13,426 | $9,791 | $38,743 | $40,510 | $45,697 | $84,197 | $427,111 |
| Current liabilities | $633,418 | $627,425 | $608,755 | $588,961 | $579,556 | $570,228 | $578,747 | $145,173 |
| Short-term debt | $122,259 | $125,259 | $114,355 | $97,710 | $95,274 | $97,900 | $97,900 | $125,397 |
| Total liabilities | $865,118 | $906,425 | $887,755 | $867,960 | $858,556 | $849,228 | $857,747 | $443,074 |
| Shareholders' equity | -$860,900 | -$892,999 | -$877,964 | -$829,218 | -$817,996 | -$803,531 | -$773,550 | -$728,033 |
| Shares outstanding | 50.65M | 11.40M | 11.40M | 11.40M | 11.40M | 11.40M | 11.40M | 11.40M |
| Cash flow statement | ||||||||
| Operating cash flow | -$6,209 | -$7,270 | -$45,597 | $2,156 | $15,851 | -$19,030 | -$161,661 | -$82,455 |
| Investing cash flow | $0 | $0 | $30,000 | $0 | -$30,000 | $0 | — | — |
| Financing cash flow | -$3,000 | $10,905 | $16,645 | $2,436 | $2,604 | -$5,000 | $72,502 | $77,068 |
| Depreciation & amortization | — | — | — | — | — | — | $12 | $13 |
Free plan shows the latest 8 periods; Pro shows all 64 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.